Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig Slingluff, M.D.
University of Virginia Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
- Durham Regional Cancer Centre
Oshawa, Ontario, Canada
- Princess Margaret Hospital, Department of Medical Oncology
Toronto, Ontario, Canada
- Cisss de la Montérégie - Centre
Greenfield Park, Quebec, Canada
- Royal Victoria Hospital
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec
Québec, Canada
- Ironwood Cancer and Research Centers
Chandler, Arizona, United States
- University of Arizona Cancer Center
Tucson, Arizona, United States
- Highlands Oncology Group
Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Beverly Hills Cancer Center
Beverly Hills, California, United States
- City of Hope National Medical Center
Duarte, California, United States
- the Angeles Clinic and Research Institute
Los Angeles, California, United States
- Ucla Hematology & Oncology Clinic
Los Angeles, California, United States
- Ventura County Hematology Oncology Specialists
Oxnard, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- St. Mary'S Hospital & Medical Center Department of Pathology
San Francisco, California, United States
- Anschutz Cancer Pavilion
Aurora, Colorado, United States
- the Melanoma Center at the Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Cancer Specialists of North Florida
Jacksonville, Florida, United States
- Genesiscare Usa of Florida
Jacksonville, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Md Anderson Cancer Center-Orlando
Orlando, Florida, United States
- Ameriderm Research
Ormond Beach, Florida, United States
- Advocate Medical Group
Niles, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Investigative Clinical Research of Indiana
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Central Kentucky Research Associates
Lexington, Kentucky, United States
- University of Louisville
Louisville, Kentucky, United States
- Harry & Jeanette Weinberg Cancer Institute @ Franklin Square
Baltimore, Maryland, United States
- Ascension Providence Hospital
Southfield, Michigan, United States
- University of Minnesota Masonic Cancer Institute
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center, Mayo Clinic Rochester
Rochester, Minnesota, United States
- Center for Pharmaceutical Research
Kansas City, Missouri, United States
- Medisearch Clinical Trials
Saint Joseph, Missouri, United States
- St. Louis University Hospital
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Norris Cotton Cancer Center / Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2012
- Primary completion
- 29 Apr 2021
- Completion
- 30 Jun 2021
- Last update posted
- 24 Oct 2025
- Registered enrollment
- 504
- Registry id
- NCT01546571
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.